Document:

<PAGE>
                                                                    Exhibit 10.9

                           FORM OF STOCK OPTION GRANT

[NAME AND ADDRESS OF OPTIONEE]          Grant Date:              April 25, 2001
                                        Shares Granted:
                                        Stock Option Price:
                                        Last Date to Exercise:   04/25/2011

You have been granted the option to purchase PerkinElmer, Inc. common stock.
This grant represents a multi-year grant covering the period 2001 - 2003. The
terms of this grant are subject to both the attached Vesting Conditions for
[NAME OF OPTIONEE] Stock Option Grant dated 4/25/01 and Exhibit A - Definition
of Earnings Per Share. A brief summary of these conditions is as follows:

-    These are performance based options that have a cliff vest of 6 years with
     a 10 year term.

-    Vesting is accelerated if the following targets are met:

     -    Three (3) consecutive four quarter periods of 15% growth in EPS or

     -    50% cumulative growth in EPS in a four quarter period ending no later
          than the second quarter of 2003.

EXERCISE:

You may exercise this Option, in whole or in part, to purchase a whole number of
vested shares at any time, by following the exercise procedures set up by the
Company. All exercises must take place by the Last Date to Exercise, or such
earlier date as set out following your death, disability or your ceasing to be
an employee. The number of shares you may purchase as of any date cannot exceed
the total number of shares vested by that date, less any shares you have
previously acquired by exercising this Option.

EMPLOYMENT REQUIREMENTS:

The Plan sets out the terms and conditions that govern this grant in the event
of your termination of employment, retirement, death or total disability as
follows:

-    If your employment is terminated for reasons other than retirement, death,
     or total disability, you will be able to exercise your vested stock options
     the earlier of the Last Date to Exercise or three (3) months from
     termination date. All unvested stock options will be cancelled.

-    If you terminate at a Company-recognized retirement age, you will be able
     to exercise your vested stock options the earlier of the option's Last Date
     to Exercise or three (3) years from the effective date of termination. All
     unvested stock options will be cancelled.

-    If termination is due to your death or total disability, your unvested
     stock options become 100% vested. You, in the event of your total
     disability, or your estate, in the event of your death, have the earlier of
     the stock option's Last Date to Exercise or one (1) year to exercise these
     options.

The option may be transferred to a Family Member of the Optionee as defined in
the instructions to SEC form S-8. The transferee shall be subject to all the
terms and conditions applicable to the Option prior to the transfer. The
transfer shall not be effective until the Optionee has notified the Company in
writing that the transfer has occurred.

TAXES AND WITHHOLDING:

This option is intended to be a Non-Qualified Stock Option. In the event that
the Company determines that any federal, state, or local tax or withholding
payment is required relating to the exercise of sale of shares arising from this
grant, the Company shall have the right to require such payments from you, or
withhold such amounts from other payments due to you from the Company.

PROHIBITED ACTIVITY AGREEMENT:

This stock option grant is subject to the terms and conditions of your signed
and executed Prohibited Activity Agreement.

CHANGE OF CONTROL:

If there is a Change of Control, your unvested stock options become 100% vested.
Reference attached Change of Control Provision for the complete definition of
Change of Control.

<PAGE>

                               Vesting Conditions

                 For [NAME OF OPTIONEE] Stock Option Grant dated
                                 April 25, 2001

     The options shall fully vest on the earliest of the following dates or
events:

     (a)  The Company's earnings per share, determined as set forth in Exhibit A
hereto, for a Measurement Period ending no later than the end of the second
fiscal quarter of 2003 is at least 1.5 times the Company's earnings per share
for the Base Period. The earnings per share which is required to vest the option
shares ("Target EPS") and the earnings per share for the Base Period shall be
adjusted in accordance with Exhibit A. Earnings per share for any Measurement
Period and any adjustments thereto pursuant to Exhibit A shall be proposed by
the Company's management and verified by the Company's independent public
accountants.

     (b)  The earnings per share for each of three consecutive Measurement
Periods is at least 1.15 times the earnings per share for the Measurement Period
or the Base Period immediately preceding each such Measurement Period. The first
Measurement Period of the three consecutive Measurement Periods referred to in
the preceding sentence must begin after the end of the Base Period. The earnings
per share which is required to be achieved to vest the option shares ("Target
EPS") and the earnings per share for the Base Period shall be adjusted in
accordance with Exhibit A. Earnings per share for any Measurement Period and any
adjustments thereto pursuant to Exhibit A shall be proposed by the Company's
management and verified by the Company's independent public accountants.

     (c)  The employment with the Company of the stock option recipient
continues without interruption through April 25, 2007.

     For purposes of the foregoing provisions, the Base Period is the period of
four consecutive fiscal quarters of the Company ending with the Company's second
fiscal quarter of 2001 and a Measurement Period is any period of four
consecutive fiscal quarters of the Company ending after the end of the Base
Period.

<PAGE>

                                    EXHIBIT A

                        DEFINITION OF EARNINGS PER SHARE

     (a)  Earnings Per Share shall mean post-tax earnings per common share for
the applicable Base Period or Measurement Period determined on a fully diluted
basis as reported in the Company's consolidated financial statements, adjusted
as hereinafter described.

     (b)  If any of the following events occurs after the end of the Company's
second fiscal quarter, then in each Measurement Period in which any such event
directly affects post-tax earnings per share, as well as the Base Period, a
corresponding adjustment shall be made to arrive at EPS for such Measurement
Period or the Base Period, as the case may be:

          (1)  Any common stock split or common stock dividend, common stock
     subdivision or reclassification.

          (2)  Any change in accounting principles or Company accounting
     practices.

          (3)  Any change in laws, regulations or interpretations thereof.

          (4)  Any items of a non-recurring nature, as evidenced by their
     exclusion from adjusted earnings as presented in external earnings
     releases.

          (5)  Any extraordinary item, determined under generally accepted
     accounting principles.

     (c)  In the event a significant business is sold, earnings per share and
Target EPS (as defined in Vesting Conditions) shall be appropriately adjusted by
the earnings per share of the divested business and shall be appropriately
adjusted by the interest from the proceeds of the sale. In the event a
significant business is acquired, Target EPS shall be appropriately adjusted in
accordance with the acquisition plan approved by the Company's Board of
Directors and earnings per share shall be appropriately adjusted by the actual
results<PAGE>
                                                                   Exhibit 10.10

                        STOCK OPTION GRANT TO MR. ENGEL

John Engel                              Grant Date:              April 25, 2001
[ADDRESS]                               Shares Granted:          300,000
                                        Stock Option Price:      $61.72
                                        Last Date to Exercise:   04/25/2011

You have been granted the option to purchase PerkinElmer, Inc. common stock.
This grant represents a multi-year grant covering the period 2001 - 2003. The
terms of this grant are subject to both the attached Vesting Conditions for John
Engel Stock Option Grant dated 4/25/01 and Exhibit A - Definition of Earnings
Per Share. A brief summary of these conditions is as follows:

-    These are performance based options that have a cliff vest of 6 years with
     a 10 year term.

-    Vesting is accelerated if the targets are met:

     -    Three (3) consecutive four quarter periods of 35% NOPAT growth over
          the pro forma base year 2000 or

     -    Annual Life Sciences NOPAT of $90M in 2 years or less.

EXERCISE:

You may exercise this Option, in whole or in part, to purchase a whole number of
vested shares at any time, by following the exercise procedures set up by the
Company. All exercises must take place by the Last Date to Exercise, or such
earlier date as set out following your death, disability or your ceasing to be
an employee. The number of shares you may purchase as of any date cannot exceed
the total number of shares vested by that date, less any shares you have
previously acquired by exercising this Option.

EMPLOYMENT REQUIREMENTS:

The Plan sets out the terms and conditions that govern this grant in the event
of your termination of employment, retirement, death or total disability as
follows:

-    If your employment is terminated for reasons other than retirement, death,
     or total disability, you will be able to exercise your vested stock options
     the earlier of the Last Date to Exercise or three (3) months from
     termination date. All unvested stock options will be cancelled.

-    If you terminate at a Company-recognized retirement age, you will be able
     to exercise your vested stock options the earlier of the option's Last Date
     to Exercise or three (3) years from the effective date of termination. All
     unvested stock options will be cancelled.

-    If termination is due to your death or total disability, your unvested
     stock options become 100% vested. You, in the event of your total
     disability, or your estate, in the event of your death, have the earlier of
     the stock option's Last Date to Exercise or one (1) year to exercise these
     options.

The option may be transferred to a Family Member of the Optionee as defined in
the instructions to SEC form S-8. The transferee shall be subject to all the
terms and conditions applicable to the Option prior to the transfer. The
transfer shall not be effective until the Optionee has notified the Company in
writing that the transfer has occurred.

TAXES AND WITHHOLDING:

This option is intended to be a Non-Qualified Stock Option. In the event that
the Company determines that any federal, state, or local tax or withholding
payment is required relating to the exercise of sale of shares arising from this
grant, the Company shall have the right to require such payments from you, or
withhold such amounts from other payments due to you from the Company.

PROHIBITED ACTIVITY AGREEMENT:

This stock option grant is subject to the terms and conditions of your signed
and executed Prohibited Activity Agreement.

CHANGE OF CONTROL:

If there is a Change of Control, your unvested stock options become 100% vested.
Reference attached Change of Control Provision for the complete definition of
Change of Control.

<PAGE>

                               Vesting Conditions

                     For John Engel Stock Option Grant dated
                                 April 25, 2001

     The options shall fully vest on the earliest of the following dates or
events:

     (a)  The Life Sciences NOPAT, determined as set forth in Exhibit A hereto,
for a Measurement Period ending no later than the end of the second fiscal
quarter of 2003 is at least $90M. NOPAT with is required to be achieved to vest
the option shares ("Target NOPAT") shall be adjusted in accordance with Exhibit
A. NOPAT for any Measurement Period and any adjustments thereto pursuant to
Exhibit A shall be determined by the Company's Chief Financial Officer.

     (b)  The Life Sciences NOPAT for each of three consecutive Measurement
Periods is at least 1.35 times the Life Sciences NOPAT for the Measurement
Period or the Base Period immediately preceding each such Measurement Period.
The first Measurement Period of the three consecutive Measurement Periods
referred to in the preceding sentence must begin after the end of the Base
Period. NOPAT which is required to be achieved to vest the option shares
("Target NOPAT") and the NOPAT for the Base Period shall be adjusted in
accordance with Exhibit A. NOPAT for any Measurement Period and any adjustments
thereto pursuant to Exhibit A shall be determined by the Company's Chief
Financial Officer.

     (c)  The employment with the Company of the stock option recipient
continues without interruption through April 25, 2007.

     For purposes of the foregoing provisions, the Base Period is the pro forma
2000 fiscal year and a Measurement Period is any period of four consecutive
fiscal quarters of the Company ending after the second fiscal quarter of 2001.

<PAGE>

                                    EXHIBIT A

             DEFINITION OF NET OPERATING PROFIT AFTER TAXES (NOPAT)

     (a)  NOPAT shall mean net operating profit after taxes for the applicable
Base Period or Measurement Period, adjusted as hereinafter described.

     (b)  If any of the following events occurs after the end of the Company's
second fiscal quarter, then in each Measurement Period in which any such event
directly affects NOPAT, as well as the Base Period, a corresponding adjustment
shall be made to arrive at NOPAT for such Measurement Period or the Base Period,
as the case may be:

          (1)  Any change in accounting principles or Company accounting
     practices.

          (2)  Any change in laws, regulations or interpretations thereof.

          (3)  Any items of a non-recurring nature.

          (4)  Any extraordinary item, determined under generally accepted
     accounting principles.

     (c)  In the event a significant business is sold, NOPAT and Target NOPAT
(as defined in Vesting Conditions) shall be appropriately adjusted by the NOPAT
of the divested business. In the event a significant business is acquired,
Target NOPAT shall be appropriately adjusted in accordance with the acquisition
plan approved by the Company's Board of Directors and NOPAT shall be
appropriately adjusted by the actual results.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00036-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00036-of-00352.parquet"}]]